TGFB1 and cancer: Engrafting both LX2-stellate cells and HepG2-cancer cells in the human liver scaffolds, slightly increased TGFβ-levels in the medium compared to scaffolds engrafted by only one cell type, but overall no significant differences were seen (Figure 4—figure supplement 1B).